0721 Coave latte
BioCentury & Getty Images

Finance

French gene therapy play Coave rebrands with €21.2M series B extension

Formerly Horama, Coave is developing targeted therapies for CNS, ocular diseases

Read the full 275 word article

How to gain access

Continue reading with a
two-week free trial.